Navigation Links
Quest PharmaTech's Prostate Cancer Program Update

Trading Symbol: QPT: TSX Venture Exchange

EDMONTON, May 02, 2007 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. ("Quest" or the "Company") Quest is pleased to provide an update on the pre-clinical development of SL052 for the treatment of prostate cancer.

Prostate cancer is the second leading cause of cancer death in American men with approximately 230,000 new cases and 30,000 deaths per year. Current therapeutic modalities for localized prostate cancer are associated with significant morbidity, such as sexual and urinary dysfunction. Photodynamic therapy (PDT) is a minimally invasive treatment that may be used in benign and malignant prostate diseases. PDT is a dual selective treatment modality using light of a specific wavelength to locally activate a photosensitizer accumulated in the target tissue. This novel therapy causes a non-carcinogenic photochemical destruction of cancer cells, including those that are resistant to radiation and chemotherapy.

Quest's innovative Photodynamic Therapy (PDT) prostate cancer treatment system utilizes our patented Sonolight Technology, our proprietary and potent Hypocrellin based photosensitizer, SL052, with a novel intra-arterial drug delivery system and state of the art laser device that delivers pulsed light. Pre-clinical studies in small and large animals have demonstrated the effectiveness of SL052 in selective destruction of normal and cancerous prostate tissues, with minimal side effects. The use of 18 F FDG (flurodeoxy glucose) PET imaging pre and post PDT treatment, highlighted the complete shut down of metabolic activity at the tumor site 24 hours after PDT treatment.

The practical application of this new PDT treatment system on the prostate gland has also been demonstrated using a canine prostate model. The intra-arterial drug delivery system allows the selective and significant accumulation of the photosensitizer in the prostate which is ea
'"/>




Page: 1 2 3

Related medicine technology :

1. MediQuest Concludes Confirmatory Phase III Study of Raynaud’s Therapy
2. Geron Corp. Licensee TA Sciences Announces Landmark 7/07/07 Teleconference to Answer Questions About TA-65, Their Telomerase Activator With Proven Age Management Benefits
3. To Stent or Not: Is That the Question?
4. VioQuest Pharmaceuticals Announces Data Presentation for Its Akt Inhibitor VQD-002, at American Association for Cancer Research Annual Meeting
5. Protox Announces Positive Clinical Data from Prostate Cancer Study
6. Updated Study Results Reinforce Survival Benefit of Taxotere (Docetaxel) for Men with Advanced, Hormone-Resistant Prostate Cancer
7. Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data on Molecular Imaging Pharmaceutical for Prostate Cancer
8. Poniard Pharmaceuticals Announces Promising Data From Interim Safety Analysis of Phase 1 Combination Trials of Picoplatin in Colorectal and Prostate Cancers
9. Vakzine Projekt Management Reports Positive Clinical Trial Results With Their Therapeutic Prostate Cancer Vaccine VPM4001
10. Algeta to Present Phase II Clinical Study Data for Alpharadin in Prostate Cancer at ASCO
11. Prostate Cancer: Clinical Study Demonstrates Superior Efficacy of Docetaxel Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Quest PharmaTech Prostate Cancer Program Update
(Date:7/28/2015)... -- VirtualScopics, Inc. (NASDAQ: VSCP ), a leading ... it will report its second quarter 2015 financial results ... August 11, 2015.  Eric T. Converse , president ... chief financial officer, will host a conference call and ... a business update at 4:30 p.m. ET that afternoon.  ...
(Date:7/28/2015)... 28, 2015 Voalte, the leader in ... in purpose-built wireless communications, today announced that Bay ... 104-bed acute-care facility in Webster, Texas ... One™ solution on Spectralink PIVOT™ purpose-built smartphones for ... Voalte a member of its AIMS Partner Program ...
(Date:7/28/2015)... 28, 2015 Dipexium Pharmaceuticals, Inc. (NASDAQ: ... on the development and commercialization of Locilex® (pexiganan ... data will be presented at the American Society ... Chemotherapy and International Society of Chemotherapy,s International Congress ... in San Diego, California , ...
Breaking Medicine Technology:VirtualScopics, Inc. Schedules Second Quarter 2015 Financial Results Press Release, Conference Call And Webcast 2VirtualScopics, Inc. Schedules Second Quarter 2015 Financial Results Press Release, Conference Call And Webcast 3Bay Area Regional Medical Center Is First to Use Spectralink PIVOT with Voalte One for Caregiver Communication 2Bay Area Regional Medical Center Is First to Use Spectralink PIVOT with Voalte One for Caregiver Communication 3Dipexium Pharmaceuticals' Pexiganan Demonstrates Microbiological Activity Against Pathogens Resistant to other Topical Antibiotics 2Dipexium Pharmaceuticals' Pexiganan Demonstrates Microbiological Activity Against Pathogens Resistant to other Topical Antibiotics 3
... 2012  Boston Scientific Corporation (NYSE: BSX ) announces ... Jersey has found all the asserted patents in a suit ... judgment in favor of Boston Scientific. As ... Boston Scientific,s PROMUS® Everolimus-Eluting Coronary Stent System infringed two patents, ...
... Inc. (Nasdaq: ENMD ), a clinical-stage ... cancer, announced today that it has secured $10 ... IDG-Accel China Growth Fund II L.P. ("IDG"), Emerging ... Mak, Director of The Campbell Family Institute for ...
Cached Medicine Technology:Boston Scientific Announces Favorable Ruling in Patent Infringement Case 2Boston Scientific Announces Favorable Ruling in Patent Infringement Case 3EntreMed Secures $10 Million Strategic Financing 2EntreMed Secures $10 Million Strategic Financing 3EntreMed Secures $10 Million Strategic Financing 4EntreMed Secures $10 Million Strategic Financing 5
(Date:7/28/2015)... GA (PRWEB) , ... July 28, 2015 , ... ... been chosen as a “Top Doctor 2015” by Atlanta Magazine. In Atlanta Magazine's annual ... row by hundreds of her esteemed colleagues and peers in the metro area as ...
(Date:7/28/2015)... ... 28, 2015 , ... The PULs Cardiac Test™ identifies asymptomatic ... many of whom are missed by conventional evaluation , A currently unmet ... sub-clinical disease, who are at risk of experiencing a coronary event, and for ...
(Date:7/28/2015)... ... July 28, 2015 , ... PeopleKeys today announced that their ... the EY Entrepreneur of the Year award. The award recognizes the important strides ... the innovative work they have done in incorporating new technology, processes, and procedures ...
(Date:7/28/2015)... Hanover, MA (PRWEB) , ... July 28, 2015 , ... Please join us for the ... the Ross Ferraro Town Center located at Gary Avenue and Lies Road in Carol Stream. ... was created to raise awareness, and provide education and help to support individuals and families ...
(Date:7/28/2015)... ... 2015 , ... Intellitec Solutions has been named by Accounting Today magazine as ... of ERP Software is a look at the firms that have done the most ... such award in 2015 for Intellitec Solutions, following being named to Bob Scott’s Insights ...
Breaking Medicine News(10 mins):Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 3Health News:Utility of a novel coronary artery disease biomarker algorithm in modifying physician adherence to guideline therapy presented at 20th World Congress on Heart Disease 2Health News:Receiving Recognition for Compassionate Care and Innovative Processes: Celtic Healthcare CEO Arnie Burchianti Wins Regional EY Entrepreneur of the Year Award 2Health News:Receiving Recognition for Compassionate Care and Innovative Processes: Celtic Healthcare CEO Arnie Burchianti Wins Regional EY Entrepreneur of the Year Award 3Health News:5th Annual Step for Hope 5K Run/Walk Event in Carol Stream, IL to Benefit Renowned Brain Aneurysm Foundation 2Health News:Intellitec Solutions Named by Accounting Today as Top 100 Value Added Reseller 2
... certification of its Quality Management System which complies with the ... for the purpose of monitoring blood pressure, pulse, weight, BMI ... ... Burtonsville, MD (PRWEB) January 26, 2009 -- ...
... ABBOTT PARK, Ill., Jan. 26 Abbott ( NYSE: ... cash tender offer for all outstanding shares of common stock ... The tender offer will be made pursuant to the ... 11, 2009, by and among Abbott, Rainforest Acquisition Inc., a ...
... Treatment of Cancer on Display at the 45th Annual ... January 25-27, 2009 PALO ALTO, Calif., Jan. 26 ... cancer and other conditions is being showcased this week ... Surgeons (STS) Meeting in San Francisco. The Novalis ...
... way to boost protection from severe respiratory illnesses such as ... South Wales (UNSW) has found, but convincing a reluctant public ... world-first clinical trial of the efficacy of masks, researchers found ... likely than non-wearers to be protected against respiratory viruses, including ...
... Some Regions, These Markets Remain Stable, According to ... 26 HealthLeaders-InterStudy, a leading provider of managed ... in many regions of the country have halted ... sectors in Buffalo, N.Y., and Baton Rouge, La., ...
... Retain its Status as Decision Resources, Clinical Gold ... a New Report from Decision ResourcesWALTHAM, Mass., Jan. ... the world,s leading research and advisory firms for ... say that a therapy,s effect on maintenance of ...
Cached Medicine News:Health News:Lifeclinic International Achieves ISO 13485:2003 2Health News:Abbott to Commence Tender Offer on Jan. 27 for All Outstanding Shares of Advanced Medical Optics, Inc. 2Health News:Abbott to Commence Tender Offer on Jan. 27 for All Outstanding Shares of Advanced Medical Optics, Inc. 3Health News:Varian Medical Systems and BrainLAB to Showcase Novalis Tx(TM) Platform for Non-Invasive Image-Guided Radiosurgery 2Health News:Varian Medical Systems and BrainLAB to Showcase Novalis Tx(TM) Platform for Non-Invasive Image-Guided Radiosurgery 3Health News:Varian Medical Systems and BrainLAB to Showcase Novalis Tx(TM) Platform for Non-Invasive Image-Guided Radiosurgery 4Health News:Unmasked and vulnerable 2Health News:Hospital Expansions in Buffalo, N.Y., and Baton Rouge, La., Contribute to Recession Resilience 2Health News:Hospital Expansions in Buffalo, N.Y., and Baton Rouge, La., Contribute to Recession Resilience 3Health News:Surveyed Gastroenterologists Indicate That Humira Has Advantages Over Remicade in Maintaining Clinical Remission of Crohn's Disease 2Health News:Surveyed Gastroenterologists Indicate That Humira Has Advantages Over Remicade in Maintaining Clinical Remission of Crohn's Disease 3
... care challenge., ,The S/5 Critical Care Monitor ... solution for the varying needs of critical care. ... of parameter module options, display and mounting options, ... optimize the bedside set-up to help meet your ...
... connectivity, ,The wireless functionality is an ... that makes it possible to connect S/5 ... S/5 Central Station via Wireless LAN technology., ... of providing continuous centralized surveillance within the ...
... day surgery and post anesthesia care in one ... is a high performance monitor designed for the ... and induction rooms. It offers the flexibility of ... advanced airway gas monitoring. When paired with the ...
Anesthetists Precordial Kit incudes one set of 4 chromed plated chest pieces, a reusable monoscope of your choice, and 20 precordial adhesive discs....
Medicine Products: